Elevated afterload, neuroendocrine stimulation, and human heart failure increase BNP levels and inhibit preload-dependent SERCA upregulation

Circ Heart Fail. 2008 Nov;1(4):265-71. doi: 10.1161/CIRCHEARTFAILURE.108.785279. Epub 2008 Sep 17.

Abstract

Background: In heart failure, brain-type natriuretic peptide (BNP) is elevated and the sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) downregulated. We previously showed that preload-induced SERCA-upregulation is suppressed by exogenous BNP.

Methods and results: Here we tested the hypothesis that afterload and neurohumoral activation would counterregulate preload-dependent SERCA upregulation through BNP, which finally results in decreased SERCA levels. We studied the effects of 6 hours preload, afterload, and isoproterenol stimulation on BNP and SERCA mRNA expression in rabbit and human failing muscles strips. Preload resulted in a pronounced upregulation of SERCA by 149% (isotonic versus slack, P<0.01). This upregulation was largely suppressed in afterloaded muscles (isometric versus slack: +32%; P<0.05). Similarly, presence of isoproterenol prevented SERCA upregulation in isotonic muscles. Afterload and isoproterenol resulted in a pronounced increase in BNP expression compared with slack by 225% (P<0.05) and 198% (P<0.01), respectively. Isoproterenol also increased expression of phospholamban by 84% (P<0.01). SERCA upregulation in preloaded muscles is associated with frequency-dependent potentiation of contractile force, which is absent in afterloaded muscles. In failing human myocardium, BNP expression was upregulated compared with nonfailing (+631%; P<0.05). Neither unloading nor preload or afterload induced a change in SERCA or BNP expression after 6 hours.

Conclusions: Afterload and neuroendocrine stimulation increase BNP expression thereby causing inhibition of preload-dependent SERCA upregulation. In failing human myocardium, high BNP expression may underlie the loss of preload-dependent upregulation of SERCA. BNP may thus contribute to adverse myocardial remodelling in heart failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Calcium-Binding Proteins / metabolism
  • Cardiotonic Agents / pharmacology*
  • Female
  • Heart / physiopathology
  • Heart Failure / physiopathology*
  • Humans
  • In Vitro Techniques
  • Isoproterenol / pharmacology*
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Natriuretic Peptide, Brain / metabolism*
  • Neurosecretory Systems / drug effects
  • Neurosecretory Systems / physiopathology*
  • RNA, Messenger / metabolism
  • Rabbits
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / genetics
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism*
  • Stress, Mechanical
  • Up-Regulation / drug effects*
  • Young Adult

Substances

  • Calcium-Binding Proteins
  • Cardiotonic Agents
  • RNA, Messenger
  • phospholamban
  • Natriuretic Peptide, Brain
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Isoproterenol